An increasing number of people are becoming more concerned about their health and well-being, taking steps to adopt a healthier lifestyle
At the same time, the cash-pay market has moved fast
Medical Disclaimer: The following content is for educational purposes only and does not constitute medical advice
MEDI4166 is a proprotein convertase subtilisin/kexin type 9 (PCSK9) antibody and glucagon-like peptide-1 (GLP-1) analogue fusion molecule designed to treat patients with type 2 diabetes who are at risk for cardiovascular disease
Eden's medical team provides detailed instructions on proper medication administration and storage for patients ready to begin their health journey
Create a plan: If a patient expresses interest in reducing drinking, collaborate on actionable steps, such as setting limits, tracking intake, or engaging support groups